A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years

Pediatric Infectious Disease Journal

Volumn 19, Issue 9, 2000, Pages 848-853

  Van Der Wielen, Marie ^a   Van Damme, Pierre ^a   Collard, Françoise ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Children; Combined vaccine; Hepatitis A and B; Two dose

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE;

ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; DOSE RESPONSE; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEROCONVERSION; VACCINATION;

ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A ANTIGENS; HEPATITIS A VACCINES; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; VACCINES, COMBINED;

EID: 0033829548     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200009000-00008     Document Type: Article

References (19)

1. The first combined vaccine against hepatitis A and B: An overview
2. A two dose combined hepatitis A and B vaccine in Chinese youngsters
3. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults
4. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine
5. Prevalence of hepatitis A, B and C in the Flemish population
6. A combined vaccine against hepatitis A and B in children and adolescents
7. Two dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years
8. Comparison of the reactogenicity and immunogenicity of two different dose levels of hepatitis A vaccine in healthy children and adolescents
9. Comparison study of the immunogenicity and safety of 5- and 10-μg dosages of a recombinant hepatitis B vaccine in healthy children
10. Immunogenicity of a recombinant yeast-derived hepatitis B vaccine (Engerix B) in children
11. A 2 dose schedule for a vaccine against hepatitis A and B in adolescents, aged 1:2-15 years
12. Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults
13. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine
14. Hepatitis B vaccine series compliance in adolescents
15. Evaluation of the acceptance of hepatitis B vaccination in urban adolescents
16. Compliance of hepatitis B vaccination in patients presenting to a teenage clinic
17. Response to hepatitis A vaccine in children after a single dose with a booster administration 6 months later
18. Single-dose hepatitis A vaccine (Havrix(TM) 720 Junior) in children